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To  study  the  effects and  importance  of ﬂuoride  on FBs in the  development  of extraperiosteal  calciﬁcation
and  the  ossiﬁcation  of skeletal  ﬂuorosis,  the  presence  of  the  osteogenic  phenotype,  which  is  indicated
by  the  expression  of  core-binding  factor  1 (Cbfa1)  and  osteocalcin  (OCN),  in an  FB  cell line (L929)  and
in  osteoblasts  (OBs)  exposed  to ﬂuoride  was  determined.  Fibroblasts  and  osteoblasts  were  exposed  to
different  concentrations  of  ﬂuoride  (0, 0.0001,  0.001,  0.1, 1.0, 10.0  and  20.0  mg/L  F−). By  using  RT-PCR
and  ELISA,  the  mRNA  levels  of Cbfa1  and  OCN  were measured  at 48  h,  and the  protein  levels  of  Cbfa1
and  OCN  were  measured  at  2, 4, 24, 48  and  72 h. The  data  demonstrated  the  following:  (1) The  Cbfa1
protein  level  in  ﬂuoride-treated  ﬁbroblasts  clearly  increased  at 48  h  in the  groups  treated  with  0.0001,
0.001,  0.1, 1.0 and 20.0 mg/L  F−. The  Cbfa1  protein  level  of  the  group  treated  with  10 mg/L  F− at  72  h
was  higher  than  that  of  the control  group.  The  level  of  Cbfa1  mRNA  in  the  ﬁbroblasts  was  much  higher
at  48  h in  the  group  treated  with 10.0  mg/L  F− than  in the  control  group.  (2)  The  OCN  protein  level  in
ﬂuoride-treated  ﬁbroblasts  was  signiﬁcantly  higher  than  that  of the control  group  in the  0.0001,  0.1,
1.0,  10.0  and  20.0  mg/L  F− groups  at 2 h,  and  in  the  0.001  and 0.1  F− groups  at  4  h.  A  slightly  higher
level  of  OCN mRNA  in ﬂuoride-treated  ﬁbroblasts  was  also  found  in  the  1.0  and  20.0 mg/L  F− groups
compared  to the  control  group.  (3)  The  expressions  of  Cbfa1  and  OCN  in  osteoblasts  treated  with  the
same  experimental  conditions  as the  ﬁbroblasts  were  up-regulated  by  ﬂuoride  following  the  same  trend
as  in  the ﬁbroblasts.  Our  results  showed  an  increase  in the expression  of Cbfa1  and  OCN  in ﬁbroblasts
and  osteoblasts  exposed  to  ﬂuoride  and suggested  that the osteogenic  function  of  ﬁbroblasts  induced  by
ﬂuoride  could  play  an  important  role in  the development  of  extraperiosteal  ossiﬁcation  during  skeletal
ﬂuorosis.
© 2014  Elsevier  GmbH.  Open access under CC BY-NC-ND license.ntroduction
Extraperiosteal calciﬁcation and ossiﬁcation plays an important
ole in the development of severely disabled skeletal ﬂuoro-
is. For studying the mechanism of extraperiosteal calciﬁcation
nd ossiﬁcation during skeletal ﬂuorosis, attention is focused
n the ﬁbroblast (FB), which is the main cell type existing in
he extraperiosteal soft tissue, such as tendons and the linking
oints of ligaments. FBs are considered inducible osteogenic pre-
ursor cells (IOPC) because of their osteogenic function under
on-physiological conditions [1]. In this study, we proposed that
uoride can stimulate the osteogenic function of FBs by enhancing
∗ Corresponding author. Tel.: +86 13804302727.
E-mail  address: jingling85619287@163.com (L. Jing).
ttp://dx.doi.org/10.1016/j.jtemb.2014.02.004
946-672X © 2014 Elsevier GmbH. Open access under CC BY-NC-ND license.the expression of osteogenic markers. Although many details
remain to be studied, the interaction between ﬂuoride and FBs is
strongly analogous to the mechanism of extraperiosteal ossiﬁca-
tion. Furthermore, it has been shown that core-binding factor 1
(Cbfa1) and osteocalcin (OCN) are special markers of osteoblast-like
cell lines [2,3]. Cbfa1, an essential transcription factor in osteoblast
differentiation and bone formation [4–7] plays an essential role in
osteogenesis [8–10]. Furthermore, studies have shown that Cbfa1
plays important roles in matrix production and mineralization
[11,12]. Osteocalcin, a major noncollagenous matrix protein of
bone, dentin, and cementum, is found in tight association with
the calcium phosphate mineral phase of these tissues [13]. Con-
sequently, we focused on the expression of Cbfa1 and OCN in FBs
treated with ﬂuoride to explain the mechanism of extraperiosteal
ossiﬁcation during skeletal ﬂuorosis with the future goal of devel-
oping a cure for this disease.
X. Duan et al. / Journal of Trace Elements in Medicine and Biology 28 (2014) 278–283 279
Table  1
Primer sequences.
Accession number Gene name Forward and reverse primer Position Size (bp)
BC068988.1 -Actin 5′-CATCTCTTGCTCGAAGTCCA-3′
5′-ATCATGTTTGAGACCTTCAACA-3′
430–733 317
NM  007527.2 Cbfa1 5′-CACGACAACCGCACCATG-3′
5′-GTCCCATCTGGTACCTCTCCG-3′
234–598 166
CCCT
TAGA
M
C
F
C
M
a
o
F
i
c
l
i
g
c
2
D
O
m
s
t
a
M
b
t
m
w
s
B
s
a
t
E
t
a
W
t
o
I
o
3
n
c
w
CBC013447.1  OCN 5′-ATGAGAG
5′-CGGGCCG
aterials and methods
ell  culture and ﬂuoride treatment
ibroblast
The ﬁbroblast cell line L929 was purchased from cell bank (The
hinese Academy of Sci.) and cultured in Dulbecco’s Modiﬁed Eagle
edium (DMEM) containing 10% fetal calf serum (FCS, Gibco, USA)
t 37 ◦C in a humidiﬁed atmosphere of 5% CO2/95% air. Before ﬂu-
ride treatment, the cells were cultured in DMEM containing 5%
CS for 24 h. The MTT  results showed that the proliferous activity
ncreased signiﬁcantly in FBs exposed to certain range of ﬂuoride
oncentration (0.001 mg  F−/L) at certain time (1 h and 2 h). The pro-
iferous activity decreased with the time of culture and the doses
ncrease of ﬂuoride [14]. Thus, the ﬁbroblasts of the experimental
roups were treated with DMEM (5% FCS) containing different con-
entrations of ﬂuoride (0.0001, 0.001, 0.1, 1.0, 10.0 or 20.0 mg/L) for
, 4, 24, 48 and 72 h. Cells in the control group were cultured with
MEM (5% FCS) for the same time points.
steoblast
Primary calvarial osteoblasts were prepared from Kunming
ice. Neonatal mouse calvaria were dissected free from adherent
oft tissue, cut into pieces and sequentially digested with 0.25%
rypsin for 30 min  at 37 ◦C. Then, the cells were digested twice (1 h
t 37 ◦C each time) with 1 mg/mL  collagenase (Sigma, St. Louis,
O, USA). After this digest, the cells were washed in phosphate
uffered saline (PBS) and centrifuged at 1000 rpm for 5 min, and
he pelleted cells were resuspended in an -modiﬁcation of Eagle’s
edium (-MEM,  Gibco, Grand Island, NY, USA) supplemented
ith 10% calf serum, 100 units/mL penicillin and 100 units/mL
treptomycin. Then the cells were seeded into 25 mL  ﬂasks (Falcon;
D BioSciences, USA) and grown at 37 ◦C in a humidiﬁed atmo-
phere of 5% CO2/95% air. The cells were identiﬁed as osteoblasts by
lkaline phosphatase staining. OBs were divided into 7 groups and
reated in the manner as the ﬁbroblasts (see Section “Fibroblast”)
nzyme-linked immuno sorbent assay (ELISA)
To quantify the Cbfa1 and OCN protein levels in the cell cul-
ure supernatants, commercially available ELISA kits were used
ccording to the manufacturer’s instructions (Promega, Madison,
I, USA). All measurements were performed in duplicate. Consti-
utive protein secretion was analyzed following 2, 4, 24, 48 and 72 h
f cell culture with different concentrations of ﬂuoride.
mmunohistochemistry (IHC)
Immunohistochemistry was performed on ﬁbroblasts seeded
n slides. The ﬁbroblasts were ﬁxed in 10% formaldehyde for
0 min  and washed thoroughly with PBS. To inactivate the endoge-
ous peroxidase, the ﬁbroblasts were permeabilized in a solution
ontaining 30% H2O2 and methanol (1:50) for 30 min. This step
as followed by an incubation with the primary antibody against
bfa1/Runx2 (Santa Cruz Biotechnology, Inc) overnight at 4 ◦C, andCAGACTCCTC-3′
AGCGCCGATA-3′
1553–1800 296
then the slides were washed three times in PBS. The results were
visualized using diamino benzidine (DAB) to generate a brown pre-
cipitate, and, ﬁnally, the cells were counterstained in hematoxylin
for 10 min, dehydrated, made transparent and mounted.
Reverse  transcription polymerase chain reaction (RT-PCR)
Before ﬂuoride treatment, the cells were cultured in 5% FCS for
24 h. The ﬁbroblasts were treated with DMEM (5% calf serum) con-
taining ﬂuoride at a concentration of 0, 0.0001, 0.001, 0.1, 1.0, 10.0
or 20.0 mg/L for 2, 4, 24, 48 and 72 h. Total RNA was extracted
using TRIzol reagent (Invitrogen Inc., USA) and quantiﬁed using a
spectrophotometer. Reverse transcription of 5 g of cultured cell
total RNA was  performed for 50 min  at 42 ◦C and then 15 min
at 70 ◦C using the Super Scrip First-Strand Synthesis System for
RT-PCR (Invitrogen), which contains RT buffer, Oligo 12–18, 5×
First-Strand Solution, 10 mM dNTP, 0.1 M DTT, Super Script II (RT-
enzyme), and Rnase H (RNase inhibitor). PCR using primers for
unique sequences in each cDNA was carried out in a 25 L reac-
tion mixture that included 2.5 L Tag buffer, 0.5 L Tag, 2 L dNTP,
0.5 L each primer, 3 L template and 16 L DEPC water. For PCR,
we used the primers as Table 1. The thermal cycling conditions were
as follows: (1) initial denaturation at 94 ◦C for 2 min, (2) cycling
for the cDNA-speciﬁc annealing temperature for 30 s and 72 ◦C for
2 min, (3) ﬁnal extension at 72 ◦C for 5 min. The expected size of
the cDNA and the primers used are shown in Table 1. An equal vol-
ume from each PCR reaction was analyzed by 2% polyacrylamide
gel electrophoresis, and the gel was stained with ethidium bro-
mide. The speciﬁc bands were quantitatively analyzed by scanning
volume density using Tanon GIS-1000 densitometer and GISID soft-
ware (Tanon Inc., China) and normalized to -actin levels as an
internal control. All the following assays were performed in tripli-
cate.
Statistical analysis
The  SPSS program (version 13.0) for windows (SPSS, Chicago, IL,
USA) was  used for the statistical analyses. Values are given as the
means ± standard deviations (SD). A one-way analysis of variance
(ANOVA) was  used to evaluate the signiﬁcant differences among
group means at each time point. When ANOVA indicated a signiﬁ-
cant difference between the means, the differences were evaluated
using the Fisher protected least signiﬁcant difference (PLSD). P val-
ues less than 0.05 were considered to be signiﬁcant. The graphs of
the experimental results were generated with Graphpad Prism 5
software.
Results
The content of Cbfa1 protein in ﬁbroblasts and osteoblasts treated
with  ﬂuorideOur  IHC results showed that the Cbfa1 protein was  located
in the cytoplasm in ﬁbroblasts, and positive staining of ﬁbro-
blasts was only observed in the group treated with 0.0001 mg/L
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with ﬂuoride at 48 hig. 1. Effects of ﬂuoride on the expression of Cbfa1 protein in ﬁbroblast (DAB 400
ocated in cytoplasm and the positive staining was  only observed in the group of 0.
− (Fig. 1). The Cbfa1 protein level in ﬁbroblasts measured by
LISA was obviously increased at 48 h compared to the con-
rol group in the groups treated with 0.0001, 0.001, 0.1, 1.0 and
0.0 mg/L F− to 2.35 ± 0.08, 2.28 ± 0.09, 2.32 ± 0.09, 2.25 ± 0.08, and
.28 ± 0.09, respectively, and at 72 h in the group treated with
0 mg/L F− (2.48 ± 0.22) (Fig. 2). In osteoblasts, the Cbfa1 protein
evel increased signiﬁcantly at 4 h compared to the control group
n the groups treated with 0.0001, 0.1, 1.0 and 20.0 mg/L F− to
.91 ± 0.06, 1.92 ± 0.12, 1.95 ± 0.05, and 1.89 ± 0.03, respectively,
t 24 h in the group treated with 20 mg/L F− (2.34 ± 0.09), at 48 h in
he groups treated with 0.0001, 0.001, 0.1, 1.0, 10.0 and 20.0 mg/L
− to 2.31 ± 0.14, 2.21 ± 0.21, 2.27 ± 0.08, 2.41 ± 0.00, 2.39 ± 0.19,
nd 2.39 ± 0.19, respectively, and at 72 h in the groups treated
ith 0.0001, 0.001, 0.1, 1.0, 10.0 and 20.0 mg/L F− to 2.16 ± 0.22,
.31 ± 0.09, 2.27 ± 0.16, 2.26 ± 0.09, 2.48 ± 0.27, and 2.23 ± 0.31,
espectively (Fig. 3).
he  expression of Cbfa1 mRNA in ﬁbroblasts and osteoblasts
reated with ﬂuoride at 48 h
In ﬁbroblasts, an increasing tendency in the expression of
bfa1 mRNA was found in the ﬂuoride groups, and the high-
st expression was found in the group treated with 10 mg/L F−
1.29 ± 0.30, p < 0.05). In osteoblasts, the same tendency was found,
ig. 2. The content of Cbfa1 protein in ﬂuoride-treated ﬁbroblast (The content of
bfa1 protein in ﬁbroblast measured by ELISA increased obviously in groups of
.0001, 0.001, 0.1, 1.0 and 20.0 mg/L F− at 48 h and group of 10 mg/L F− at 72 h).: control; B: 0.0001 mg/L F− . By method of IHC, the Cbfa1 protein in ﬁbroblast was
g/L F−).
and the highest expression was observed in the group treated with
0.0001 mg/L F− (p < 0.05) (Fig. 4).
The  OCN protein level in ﬁbroblasts and osteoblasts treated with
ﬂuoride
Compared  to the control group, the OCN protein level in
ﬁbroblasts was  higher at 2 h in the groups treated with 0.0001,
0.1, 1, 10 and 20 mg/L F− to 2.61 ± 0.22, 2.52 ± 0.18, 2.52 ± 0.18,
2.42 ± 0.29, and 2.42 ± 0.18, respectively and at 4 h in the groups
treated with 0.001 and 0.1 mg/L F− to 2.35 ± 0.08 and 2.35 ± 0.22,
respectively. In contrast, the OCN protein level in ﬁbroblasts was
signiﬁcantly lower than in the control at 48 h in the groups treated
with 0.001 and 10 mg/L F− to 2.06 ± 0.05 and 2.05 ± 0.12, respec-
tively, and at 72 h in the groups treated with 0.0001, 0.1, and
1.0 mg/L F− to 2.11 ± 0.10, 2.07 ± 0.11, and 2.05 ± 0.15, respectively.
In osteoblasts, the OCN protein level increased obviously in all of
the ﬂuoride groups (Figs. 5 and 6).
The expression of OCN mRNA in ﬁbroblasts and osteoblasts treatedIn ﬁbroblasts, the highest expression of OCN mRNA was  found
in the groups treated with 1 and 20 mg/L F−, but these data had no
Fig. 3. The content of Cbfa1 protein in ﬂuoride-treated osteoblast (Compared to
the control group, the content of Cbfa1 protein increased signiﬁcantly in groups of
0.0001, 0.1, 1.0 and 20.0 mg/L F− at 4 h, 20 mg/L F− at 24 h, 0.0001, 0.001, 0.1, 1.0,
10.0  and 20.0 mg/L F− at 48 h, 0.0001, 0.001, 0.1, 1.0, 10.0 and 20.0 mg/L F− at 72 h).
X. Duan et al. / Journal of Trace Elements in Medicine and Biology 28 (2014) 278–283 281
Fig. 4. Expression of Cbfa1 mRNA in ﬂuoride-treated ﬁbroblast and osteoblast at
48 h (A: bands of marker (-actin) in ﬂuoride-treated ﬁbroblast and osteoblast at
48 h 1–7 were groups of 0.0001, 0.001, 0.1, 1, 10 and 20 mg/L F− and control; M:
marker,  down to top: 100, 200, 300, 500, 900 and 1000 bp. B: bands of Cbfa1 mRNA
in ﬂuoride-treated ﬁbroblast and osteoblast at 48 h, 1–7 were groups of 0, 0.0001,
0.001,  0.1, 1, 10 and 20 mg/L F− and control; M:  marker, down to top: DL1000 (100,
200, 300, 500, 900 and 1000 bp). C: expression of Cbfa1 mRNA in ﬂuoride-treated
ﬁbroblast  and osteoblast at 48 h. In ﬁbroblast, the increasing tendency of express of
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Fig. 5. The content of OCN protein in ﬂuoride-treated ﬁbroblast (Compared to the
control group, the content of OCN protein in ﬁbroblast was higher in groups of
− −
ulate the synthesis of the extracellular matrix, the precipitation
of the bone matrix and the expression of the OCN gene. OCN, a
major non-collagenous matrix protein secreted by osteoblasts [21]bfa1 mRNA was found in ﬂuoride groups and the highest expression was in group of
0 mg/L F− (p < 0.05); In osteoblast, the same tendency was  showed and the highest
xpression  was observed in group of 0.0001 mg/L F− (p < 0.05)).
tatistical signiﬁcance. In osteoblasts, the expression of OCN mRNA
ncreased slightly in all ﬂuoride groups except for the 20 mg/L F−
roup (Fig. 7).
iscussion
Two  osteoblast-speciﬁc cis-acting elements (OSEs) were identi-
ed in the promoter of the OCN gene: OSE1 and OSE2 [8,15]. This
ed to the identiﬁcation of Cbfa1 as the ﬁrst osteoblast-speciﬁc tran-
cription factor. During embryonic development, Cbfa1 expression
recedes osteoblast differentiation and is restricted to the transi-
ion of mesenchymal cells to chondrocytes or osteoblasts [16–19].
ubsequently, as the earliest and most speciﬁc marker of osteo-
enesis, Cbfa1 expression is a particular marker of osteoblasts [20]
nd has a lower level of expression in hypertrophic chondrocytes.
n cell culture, Cbfa1 acts as an activator of transcription and can0.0001, 0.1, 1, 10 and 20 mg/L F at 2 h, 0.001, 0.1 mg/L F at 4 h, while that was
lower  signiﬁcantly in group of 0.001, 10 mg/L F− at 48 h, 0.0001, 0.1 and 1.0 mg/L F−
at 72 h).
induce osteoblast-speciﬁc gene expression in ﬁbroblasts and even
myoblasts. In addition to its critical role during osteoblast differen-
tiation, Cbfa1 controls bone formation by differentiated osteoblasts.
As noted above, Cbfa1 regulates the expression of OCN, a gene
expressed only in terminally differentiated osteoblasts. Cbfa1 bind-
ing sites are also present in the regulatory sequences of most genes
required for the elaboration of a bone extracellular matrix. Cbfa1
is mainly expressed in osteoblasts and is the most speciﬁc and
important transcription factor that has been discovered thus far
for osteoblast differentiation and bone formation. Cbfa1 can reg-Fig. 6. The content of OCN protein in ﬂuoride-treated osteoblast (In osteoblast, the
content of OCN protein increased obviously in all of ﬂuoride groups (p < 0.05)).
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Fig. 7. The expression of OCN mRNA in ﬁbroblast and osteoblast exposed to ﬂuoride
at 48 h (A: bands of OCN mRNA in ﬂuoride-treated ﬁbroblast and osteoblast at 48 h,
1–7 were groups of 0, 0.0001, 0.001, 0.1, 1, 10 and 20 mg/L F− and control; M: marker,
down to top: DL2000 (100, 250, 500, 750, 1000, 1600 and 2000 bp). B: expression
of  OCN mRNA in ﬂuoride-treated ﬁbroblast and osteoblast at 48 h. In ﬁbroblast, the
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oigher expression of OCN mRNA was found in groups of 1, 20 mg/L F− but having no
tatistical signiﬁcance. In osteoblast, the expression of OCN mRNA increased slightly
n all ﬂuoride groups excepting for the group of 20 mg/L F−).
nd odontoblasts, was discovered in the mid-seventies by Price and
oworkers [22] and was found to be in tight association with the cal-
ium phosphate mineral phase of bone, dentin, and cementum. FBs
re considered terminally differentiated cells, but the dedifferenti-
tion or cell phenotype transformation of FBs can occur as the result
f a repressed gene being reactivated or an abnormal gene being
ctivated under non-physiological conditions. We  deduce that FBs
an transform into OBs because both FBs and OBs have the same
rigin, they have a high level of cell phenotype overlap and they
ifferentiate in a similar manner. OBs from patients with osteo-
orosis have been shown to present a ﬁbroblast-like appearance,
ndicated by the partial loss of expression of ALP, OCN and CO I
nd the expression of non-speciﬁc collagen III. Many reports show
hat FBs exhibit an OB phenotype after activating the Cbfa1 gene
nduced by bFGF, BMP2, TNF and so on.
Both osteoblasts and ﬁbroblasts are of mesenchymal origin. The
nly morphological feature speciﬁc to osteoblasts is located out-
ide the cell in the form of a mineralized extracellular matrix. All
he genes expressed in ﬁbroblasts are also expressed in osteoblasts
xcept for two osteoblast-speciﬁc transcripts that have been
dentiﬁed: Cbfa1 and OCN. The osteoblast can be viewed as a sophis-
icated ﬁbroblast [23]. Human skin ﬁbroblasts can be induced to
 pro-osteoblast state by expressing Cbfa1 in combination with
NF- and BMP-2 [24]; the expression of ALP and OCN has been
bserved in rabbit skin ﬁbroblasts after being transfected with the
bfa1 gene [25]. In osteoporosis patients, osteoblasts were found
o be similar to ﬁbroblasts morphologically and to synthesize ALP,
CN and COL I at low levels. Furthermore, ﬁbroblasts from the
oint in osteoporosis patients were capable of transforming into
steoblasts under the effect of BMP-2 and TGF-.edicine and Biology 28 (2014) 278–283
It is well known that ﬂuoride is a factor that seems to particu-
larly alter the activity of osteoblasts, both systemically and locally
or through their presence in apatite crystals. Fluoride also seems
to change the amount of bone mass in rats in a dose-dependent
manner, and has been used in protocols for the treatment of osteo-
porosis. Some research has provided evidence that ﬂuoride acts
directly on osteoblasts to impair early extracellular matrix biosyn-
thesis and is associated with the activity and maturation stage of
intrinsic osteoblasts [26].
We  propose that the expression of Cbfa1 and OCN in ﬁbro-
blasts can be induced by ﬂuoride resulting in the stimulation of the
osteogenic function of ﬁbroblasts. There is no united opinion about
whether other cells except for osteoblasts can express “Cbfa1” and
“OCN” or not. Most of academics think that there is no expression
of “Cbfa1” and “OCN” in FBs under physical conditions, but some
researcher argues that there has a weak expression in skin FB [27].
By using ELISA and IHC methods, the Cbfa1 and OCN protein levels
in osteoblasts and ﬁbroblasts and in cell culture ﬂuid were mea-
sured. A similar increasing tendency in the level of Cbfa1 protein
was found in ﬁbroblasts and osteoblasts. However, in osteoblasts,
the increase was much greater and lasted much longer than in ﬁbro-
blasts. Fluoride also up-regulated the expression of the OCN protein
in ﬁbroblasts and osteoblasts, and this effect was  much stronger in
osteoblasts.
The expression levels of Cbfa1 and OCN mRNA were detected
using RT-PCR and were found to be increased by ﬂuoride treatment.
When Cbfa1 is expressed in non-skeletal cells, the cells assume
many of the characteristics of osteoblasts. For example, the secre-
tion of OCN by ankylosing spondylitis (AS) ﬁbroblasts is higher than
that of normal ﬁbroblasts. The facts discussed above show that AS
ﬁbroblasts have the same biological characteristics as osteoblasts.
A higher expression level of OCN indicates the enhancement of
osteogenesis. Our results indicated that ﬂuoride up-regulated the
expression of Cbfa1 and OCN mRNA and protein in ﬁbroblasts as
well as osteoblasts. These results show that skeletal ﬂuorosis is
mainly characterized by a high bone turnover state due to active
osteoblasts. On the other hand, these results also presented the
following clues: (1) the expression of Cbfa1 and OCN exist even
in terminally differentiated cells, such as ﬁbroblasts, but in a weak
degree; (2) ﬂuoride obviously enhances the levels of Cbfa1 and OCN.
Abnormal intramembranous ossiﬁcation and endochondral
ossiﬁcation can be induced by both the decreased and increased
expression of Cbfa1. Fibrodysplasia ossiﬁcans progressive (FOP), a
rare genetic disease, is characterized by sporadic ectopic ossiﬁca-
tion in muscle. The expression of Runx2/Cbfa1 in FOP cells was
observed in the early stages of the disease. Extraperiosteal soft tis-
sue is composed of dense connective tissue that has no osteogenic
capability in the physiological environment. Our results suggest
that ﬂuoride enhances the mRNA and protein levels of Cbfa1 and
OCN.
This paper is the ﬁrst to report that ﬂuoride can induce the
osteogenic phenotype in FBs. These results coincided with our
hypothesis. The studies discussed above demonstrated the critical
function of Cbfa1 in the pathogenesis of extraperiosteal ossiﬁca-
tion. Determining the causal relationships between ﬂuoride, FBs
and extraperiosteal ossiﬁcation will help elucidate the mechanism
of the promotion of osteogenesis of FBs by ﬂuoride. Future work in
this area will explain the pathogenesis of calciﬁcation and osteo-
genesis in extraperiosteal tissues and help establish the scientiﬁc
policy for protecting disabled skeletal ﬂuorosis; it will also give aid
in the study of other similar diseases.Conﬂict of interest
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